Journal: Journal of Translational Medicine
Article Title: Micheliolide suppresses epithelial-mesenchymal transition of lens epithelial cells via downregulating matrix metalloproteinase 8 to ameliorate posterior capsular opacification
doi: 10.1186/s12967-026-07890-z
Figure Lengend Snippet: Identification of Micheliolide, a potential MMP8 regulator. A , qRT-PCR analysis of MMP8 expression in capsular tissues 24 hours after ECLE surgery, combined with anterior chamber injection of saline or MCL, n = 3, N = 18. B , Western blot analysis and quantification of MMP8 protein levels in capsular tissues 24 hours after ECLE surgery with anterior chamber injection of saline or MCL, n = 4, N = 20. C , qRT-PCR analysis of MMP8 expression in LECs pretreated with or without 5 μmol/L MCL and stimulated with 10 ng/mL TGF-β2 for 48 hours, n = 6. D , Western blot and corresponding quantification of MMP8 protein expression in LECs pretreated with or without 5 μmol/L MCL followed by stimulation with 10 ng/mL TGF-β2 for 48 hours, n = 4. E , Molecular docking simulation of Micheliolide and MCL, with the interacting MMP8 amino acids represented by blue sticks. F , CETSA was used to assess the thermal instability of the interaction between MMP8 and MCL over the temperature range of 58 °C to 78 °C, n = 4
Article Snippet: To explore the role of Matrix Metalloproteinase 8 (MMP8) in the effect of MCL on EMT, a MMP8 inhibitor (Cat. HY-N1454, MedChemExpress, State of New Jersey, USA), referred to as M8I, was used in the present study.
Techniques: Quantitative RT-PCR, Expressing, Injection, Saline, Western Blot